EVAPORATIVE NANOCRYSTALLIZATION FOR ENHANCED SOLUBILITY AND BIOAVAILABILITY OF SULFASALAZINE
Monica Rp. Rao* and V.M. Pawar
Abstract
The purpose of the present study was to increase the aqueous solubility
of sulfasalazine (0.045mg/ml) by nanaocrystallization and preparation
of controlled multiparticulate drug delivery. Sulfasalazine is mainly
used for inflammatory bowel diseases (Crohn’s colitis and ulcerative
colitis). Sulfasalazine nanosuspensions were prepared by bottom up i.e.
antisolvent precipitation technique using stabilizers such as
tocopherolpolythytlene glycol succinate and polyvinylpyrrolidone K30
in combination (30%:70%). Nanosuspensions were characterized for
particle size distribution, polydispersity index and zeta potential. Plain
sulfasalazine and lyophilized sulfasalazine were evaluated and
compared to each other by FTIR, PXRD, FESEM, saturation solubility
and wettability. A 32factorial design was used to examine the effect of
independent variables like stabilizer concentration and speed of stirring on particle size.
Optimized batch had particle size of 251 ±6.23 nm and polydispersity index of 0.171. Zeta
potential values ranged from -5 to -13 mV. Optimized nanosuspension was loaded on
Espheres by pan coating, followed by coating with pH responsive polymers Eudragit S100
and Eudragit L100 for controlled drug release. Espheres were evaluated for drug content, (i.e.
91% to 94% for sulfasalazine suspension and 100% to 101% for sulfasalazine) and drug
release kinetics (Sulfasalazine suspension secondary coated Espheres were found to 99.20 %
drug release and Sulfasalazine nanosuspension secondary coated Espheres released 94.3 % of
drug in 10 h). Results of evaluations indicate that multiparticulate systems are beneficial for
treatment of inflammatory bowel diseases (IBD). It was concluded from the study that
Eudragit-coated Espheres were promising carriers for faster but controlled and uniform drug
release.
Keywords: Solubility, Nanocrystals, Stabilization, Coating, Controlled drug delivery.
[Full Text Article]